Pharmena S.A. (PHR) Stock Statistics & Valuation Metrics
Total Valuation
Pharmena S.A. has a market cap or net worth of PLN 32.97M. The enterprise value is PLN 34.98M.
- Market Cap
- PLN 32.97M
- Enterprise Value
- PLN 34.98M
Share Statistics
Pharmena S.A. has 11,137,758 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 11,137,758
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Pharmena S.A.’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -32.65%.
- Return on Equity (ROE)
- -0.29
- Return on Assets (ROA)
- -0.25
- Return on Invested Capital (ROIC)
- -32.65%
- Return on Capital Employed (ROCE)
- -0.33
- Revenue Per Employee
- 225.29K
- Profits Per Employee
- -395.57K
- Employee Count
- 7
- Asset Turnover
- 0.14
- Inventory Turnover
- 0.54
Valuation Ratios
The current PE Ratio of Pharmena S.A. is -10.64. Pharmena S.A.’s PEG ratio is 0.20.
- PE Ratio
- -10.64
- PS Ratio
- 22.57
- PB Ratio
- 4.03
- Price to FCF
- -9.66
- Price to Operating Cash Flow
- -10.85
- PEG Ratio
- 0.20
Income Statement
In the last 12 months, Pharmena S.A. had revenue of 1.58M and earned -2.77M in profits. Earnings per share was -0.25.
- Revenue
- 1.58M
- Gross Profit
- 1.19M
- Operating Income
- -3.28M
- Pretax Income
- -2.74M
- Net Income
- -2.77M
- EBITDA
- -3.16M
- Earnings Per Share (EPS)
- -0.25
Cash Flow
In the last 12 months, operating cash flow was -3.04M and capital expenditures -456,000, giving a free cash flow of -3.41M billion.
- Operating Cash Flow
- -3.04M
- Free Cash Flow
- -3.41M
- Free Cash Flow per Share
- -0.31
Dividends & Yields
Pharmena S.A. pays an annual dividend of PLN 2.36, resulting in a dividend yield of 79.73%
- Dividend Per Share
- PLN 2.36
- Dividend Yield
- 79.73%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.35%
- Earnings Yield
- -9.27%
Stock Price Statistics
- Beta
- 0.35
- 52-Week Price Change
- -11.90%
- 50-Day Moving Average
- 3.09
- 200-Day Moving Average
- 3.25
- Relative Strength Index (RSI)
- 43.32
- Average Volume (3m)
- 3,185
Important Dates
Pharmena S.A. upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- May 22, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- Sep 10, 2026
Financial Position
Pharmena S.A. as a current ratio of 9.20, with Debt / Equity ratio of 3.79%
- Current Ratio
- 9.20
- Quick Ratio
- 8.47
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.00
- Interest Coverage Ratio
- -164.05
Taxes
In the past 12 months, Pharmena S.A. has paid 25.00K in taxes.
- Income Tax
- 25.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Pharmena S.A. EV to EBITDA ratio is -10.87, with an EV/FCF ratio of -9.63.
- EV to Sales
- 22.49
- EV to EBITDA
- -10.87
- EV to Free Cash Flow
- -9.63
- EV to Operating Cash Flow
- -10.81
Balance Sheet
Pharmena S.A. has PLN 421.00K in cash and marketable securities with PLN 314.00K in debt, giving a net cash position of PLN 107.00K billion.
- Cash & Marketable Securities
- PLN 421.00K
- Total Debt
- PLN 314.00K
- Net Cash
- PLN 107.00K
- Net Cash Per Share
- PLN 0.01
- Tangible Book Value Per Share
- PLN 0.58
Margins
Gross margin is 79.95%, with operating margin of -228.54%, and net profit margin of -209.24%.
- Gross Margin
- 79.95%
- Operating Margin
- -228.54%
- Pretax Margin
- -208.42%
- Net Profit Margin
- -209.24%
- EBITDA Margin
- -206.91%
- EBIT Margin
- -216.29%
Analyst Forecast
The average price target for Pharmena S.A. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 64.34%
- EPS Growth Forecast
- -71.56%
